Nuclear Imaging Equipment Market Size & Growth Forecast 2027–2036, By Segments (Modality, Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Nuclear Imaging Equipment Market size stood at USD 6.9 billion in 2026 and is predicted to grow at a 3.33% CAGR from 2027 to 2036, reaching USD 9.57 billion by 2036. The industry revenue for 2027 is estimated at USD 7.09 billion.
Get more details on this report
Request Free Sample ReportNuclear Imaging Equipment Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 45.39% of the market in 2026, driven by advanced diagnostic imaging infrastructure, steady equipment replacement demand, and continued investment in nuclear medicine across major clinical applications.
- Asia Pacific is expected to grow at a 3.88% CAGR as healthcare providers expand diagnostic services, invest in imaging infrastructure, and integrate nuclear imaging into routine clinical care.
Segment Momentum
- SPECT accounted for a 60.77% share in 2026 due to its broad clinical adoption, established diagnostic workflows, extensive installed base, and continued replacement demand across healthcare facilities.
- Cardiology is the fastest-growing application as providers increasingly adopt functional imaging to support earlier cardiac assessment and more targeted treatment decisions for cardiovascular conditions.
Market Expansion Drivers
- Rising global cancer prevalence driving demand for PET and SPECT diagnostic imaging systems.
- Advancements in PET and SPECT imaging technologies improving diagnostic precision and workflow efficiency.
- Expanding healthcare infrastructure investment increasing nuclear imaging equipment deployment in hospitals.
Leading Market Participants
- Key players in the nuclear imaging equipment market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), United Imaging Healthcare Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Fujifilm Holdings Corporation (Japan), Cubresa Inc. (Canada), Neusoft Medical Systems Co., Ltd. (China).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 6.9 billion
- 2027 Estimated Market Size: USD 7.09 billion.
- Projected Market Size: USD 9.57 billion by 2036
- Growth Forecast: 3.33% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: SPECT (Modality) | Oncology (Application) | Hospitals (End-use)
- Emerging Opportunity Segment: PET (Modality) | Cardiology (Application) | R&D (End-use)
Market Growth Drivers and Industry Trends
Rising global cancer prevalence driving demand for PET and SPECT diagnostic imaging systems
The increasing prevalence of cancer is creating sustained demand for advanced diagnostic and disease-monitoring technologies, supporting the nuclear imaging equipment market through greater utilization of PET and SPECT systems. These modalities provide functional and molecular information that can complement anatomical imaging, allowing clinicians to identify abnormal tissue activity, assess disease progression, and support treatment planning. PET is particularly valuable in oncology for detecting and characterizing metabolic activity, while SPECT can provide functional imaging across several clinical applications. As healthcare systems place greater emphasis on earlier diagnosis and more precise assessment of cancer, nuclear imaging is becoming an important component of specialized diagnostic workflows.
Advancements in PET and SPECT imaging technologies improving diagnostic precision and workflow efficiency
Technological improvements in detector sensitivity, image reconstruction, motion correction, and system design are enhancing the performance of PET and SPECT platforms, strengthening the nuclear imaging equipment market. Improved image quality allows clinicians to identify and evaluate smaller or less distinct areas of abnormal activity while advanced reconstruction techniques can help reduce imaging artifacts and improve interpretability. Developments that streamline acquisition and processing can also support more efficient examination workflows, helping imaging departments manage patient throughput while maintaining diagnostic quality. Integration with digital technologies and increasingly sophisticated software further enables imaging systems to provide more consistent and clinically useful information across a range of nuclear medicine applications.
Expanding healthcare infrastructure investment increasing nuclear imaging equipment deployment in hospitals
Investment in hospital infrastructure and specialized diagnostic services is widening access to advanced nuclear medicine capabilities, creating favorable conditions for the nuclear imaging equipment market. Healthcare providers are developing and upgrading imaging departments to strengthen diagnostic capacity, improve access to specialized examinations, and support increasingly sophisticated clinical pathways. Installation of PET and SPECT systems within hospitals can enhance the availability of oncology, cardiology, neurology, and other functional imaging services, reducing dependence on limited specialized facilities. Modernization efforts also encourage healthcare institutions to replace aging equipment with systems offering improved imaging performance, workflow capabilities, and integration with broader hospital information environments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global cancer prevalence driving demand for PET and SPECT diagnostic imaging systems | 2.20% | High | North America, Europe | High | Near Term |
| Advancements in PET and SPECT imaging technologies improving diagnostic precision and workflow efficiency | 1.90% | High | North America, Asia Pacific | High | Mid Term |
| Expanding healthcare infrastructure investment increasing nuclear imaging equipment deployment in hospitals | 1.70% | High | Asia Pacific, Latin America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The nuclear imaging equipment market was led by North America, which held a 45.39% share in 2026, reflecting its advanced diagnostic infrastructure, established nuclear medicine capabilities, and strong demand for sophisticated medical imaging technologies. Extensive use of imaging in oncology, cardiology, and other specialized diagnostic applications supports equipment demand across hospitals and diagnostic facilities. High healthcare spending, continued investments in medical technology, and the presence of experienced clinical and research institutions further contribute to the region's strong market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is experiencing the fastest growth, supported by expanding healthcare access, increasing prevalence of chronic and complex diseases, and growing adoption of advanced diagnostic technologies. Governments and healthcare providers are strengthening medical infrastructure and investing in modern imaging capabilities to improve diagnostic capacity. Rising awareness of early disease detection, expanding specialist healthcare services, and improvements in nuclear medicine facilities are encouraging broader adoption, while technological modernization is creating additional opportunities for equipment deployment.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Imaging InfrastructureGermany focuses on expanding high-performance nuclear imaging capabilities across university hospitals and specialized diagnostic centers. Demand in Germany is supported by investment in hybrid imaging technologies and efficient equipment utilization for complex clinical applications.
France 🇫🇷
Hospital Modernization FocusFrance continues investing in modernization of nuclear imaging departments to improve diagnostic capacity across public healthcare facilities. Procurement priorities in France increasingly favor reliable systems with efficient imaging performance, lower maintenance requirements, and compatibility with multidisciplinary care pathways.
Italy 🇮🇹
Diagnostic Capacity ExpansionItaly is expanding access to modern nuclear imaging equipment through hospital upgrades and regional healthcare investments. Medical providers in Italy are prioritizing dependable imaging technologies that enhance diagnostic workflows while supporting efficient operation within established healthcare facilities.
Japan 🇯🇵
Aging Care DiagnosticsJapan places strong emphasis on nuclear imaging equipment that supports oncology, neurology, and cardiovascular diagnostics for an aging population. Healthcare institutions in Japan continue modernizing imaging systems while seeking compact, high-efficiency technologies that fit existing clinical infrastructure.
South Korea 🇰🇷
Digital Imaging IntegrationSouth Korea is strengthening adoption of nuclear imaging equipment through digitally connected hospitals and advanced diagnostic workflows. Healthcare providers in South Korea increasingly favor systems that combine high-resolution imaging with streamlined data integration and clinical efficiency.
United States 🇺🇸
Advanced Clinical AdoptionThe U.S. nuclear imaging equipment market emphasizes replacement of aging imaging systems with advanced PET and SPECT platforms that improve diagnostic accuracy and workflow efficiency. Healthcare providers in the U.S. also prioritize integration with digital imaging networks and AI-enabled image analysis.
Segment Leadership and Growth Trends
Nuclear Imaging Equipment Market Share (%), by Modality, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportModality Segment Analysis: SPECT (Largest Segment) vs PET (Fastest-Growing Segment)
SPECT held the largest position in the nuclear imaging equipment market in 2026, accounting for a 60.77% share. Its strong market presence is supported by broad clinical utility in functional imaging and its established role in diagnosing and monitoring a range of cardiovascular, neurological, and other medical conditions. SPECT systems provide healthcare professionals with functional information that complements conventional anatomical imaging, supporting more informed clinical assessment. Their established infrastructure, familiarity among healthcare providers, and continued need for accessible nuclear imaging contribute to the segment's sustained position.
PET is the fastest-growing modality segment, driven by increasing demand for advanced functional and molecular imaging that can provide detailed information about disease activity. PET plays an important role in identifying metabolic changes and supporting disease characterization, particularly in applications where functional information is critical to treatment planning and monitoring. Expanding use of precision-oriented diagnostic approaches and greater emphasis on early and accurate disease assessment are strengthening demand for PET-based imaging technologies.
Application Segment Analysis: Oncology (Largest Segment) vs Cardiology (Fastest-Growing Segment)
In the nuclear imaging equipment market, oncology represented the largest application segment in 2026, with a 51.93% share. Nuclear imaging is extensively used in cancer diagnosis, staging, treatment planning, and monitoring because functional imaging can help identify disease activity and evaluate treatment response. The increasing emphasis on early detection and personalized treatment strategies continues to support nuclear imaging adoption in oncology. Its ability to provide clinically relevant information beyond structural imaging further strengthens the importance of this application.
Cardiology is the fastest-growing application segment, supported by increasing use of nuclear imaging to evaluate cardiac function, blood flow, and disease-related changes. Functional imaging can assist clinicians in assessing cardiovascular conditions and informing treatment decisions, particularly when anatomical information alone is insufficient. Growing emphasis on earlier cardiovascular assessment, risk stratification, and comprehensive diagnostic evaluation is creating stronger demand for nuclear imaging equipment in cardiology.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Modality | SPECT, PET | SPECT | PET |
| Application | Cardiology, Oncology, Neurology, Others | Oncology | Cardiology |
| End-use | Hospitals, Imaging Centers, R&D, Others | Hospitals | R&D |
Competitive Landscape and Market Positioning
Top players in the nuclear imaging equipment market:
1. GE HealthCare Technologies Inc. (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. United Imaging Healthcare Co. Ltd. (China)
6. Mediso Medical Imaging Systems Ltd. (Hungary)
7. Fujifilm Holdings Corporation (Japan)
8. Cubresa Inc. (Canada)
9. Neusoft Medical Systems Co. Ltd. (China)
The nuclear imaging equipment market is transforming through the integration of artificial intelligence and advanced visualization technologies into diagnostic imaging systems. Market participants are focusing on improving scan efficiency, image clarity, and workflow automation to support faster and more accurate clinical decision-making. Demand for early disease detection and precision diagnostics is also encouraging continuous innovation in imaging equipment capabilities.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| United Imaging Healthcare Co. Ltd. (China) | |||||||
| Mediso Medical Imaging Systems Ltd. (Hungary) | |||||||
| Fujifilm Holdings Corporation (Japan) | |||||||
| Cubresa Inc. (Canada) | |||||||
| Neusoft Medical Systems Co. Ltd. (China). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Shanghai United Imaging Healthcare Co., LTD. | Jul-24 | Shanghai United Imaging Healthcare installed its first PET/CT scanner in Mexico at the Instituto Nacional de Pediatría, marking an expansion of its advanced nuclear imaging footprint into Latin America. The deployment reflects growing international adoption of the company’s diagnostic imaging systems and strengthens its presence in emerging healthcare markets focused on upgrading molecular imaging infrastructure. |
| GE Healthcare | Jun-24 | GE Healthcare introduced the MINItrace Magni compact cyclotron to enable in-house production of PET tracers and radiometals, supporting decentralized radiopharmaceutical workflows. The system is positioned to enhance hospital autonomy in tracer supply and improve operational efficiency across nuclear medicine departments by reducing dependency on external isotope suppliers and improving imaging workflow reliability. |
| GE Healthcare | Jun-24 | GE Healthcare launched the Omni Legend 21 cm PET/CT system designed to address rising demand for high-performance molecular imaging. The system targets improved diagnostic throughput and image quality across diverse clinical settings, reinforcing GE Healthcare’s portfolio expansion in advanced PET/CT solutions for oncology and cardiology imaging applications. |
| GE Healthcare | Jun-24 | GE Healthcare introduced Clarify DL, a deep learning-based reconstruction technology aimed at improving PET/CT image clarity and diagnostic accuracy. The solution integrates AI-driven processing to enhance image consistency and reduce noise, supporting more efficient interpretation workflows and strengthening GE Healthcare’s position in software-enabled nuclear imaging innovation. |
| GE Healthcare | Feb-24 | GE Healthcare entered a three-year collaboration with MedQuest Associates to enhance multi-site outpatient imaging network performance. The initiative focuses on integrating advanced imaging technologies with operational infrastructure to improve patient care delivery, optimize workflow efficiency, and strengthen scalability across distributed diagnostic imaging centers in outpatient healthcare environments. |
| Koninklijke Philips N.V. | May-23 | Philips, Elekta, and Mercurius Health signed a three-year agreement to deploy diagnostic and therapeutic oncology equipment and integrated informatics solutions at the newly acquired Robert Janker Klinik cancer center in Germany. The initiative supports modernization of oncology imaging and treatment infrastructure within a consolidated clinical care environment. |
| Canon Inc. | Nov-22 | Canon established Canon Healthcare USA, Inc. to expand its medical business operations in the United States. The new subsidiary strengthens Canon’s strategic positioning in the North American healthcare imaging market and supports broader commercialization of its medical imaging technologies, including nuclear and diagnostic imaging solutions. |
| Siemens Healthineers | Jun-22 | Siemens Healthineers launched the Symbia Pro.specta SPECT/CT system, integrating advanced SPECT and CT imaging capabilities. The system received CE mark and FDA clearance and features low-dose CT technology with up to 64-slice imaging, supporting improved diagnostic precision and reinforcing Siemens’ portfolio in hybrid nuclear imaging systems. |
| Mediso Ltd | Apr-22 | Mediso Ltd acquired Bartec Technologies Ltd, a UK-based provider of nuclear medicine and molecular imaging equipment distribution and support services. The acquisition strengthens Mediso’s commercial and service capabilities in the UK and Ireland, enhancing its regional market penetration and expanding its installed base support infrastructure in nuclear imaging systems. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Nuclear Imaging Equipment Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Mobility | Fixed Systems, Portable Systems, Mobile Systems |
| Purchase Model | Capital Purchase, Leasing, Managed Equipment / Equipment-as-a-Service |
| Equipment Utilization | Low-Volume Facilities, Medium-Volume Facilities, High-Volume Facilities |
Nuclear Imaging Equipment Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Radiopharmaceutical Supply Chain Impact Analysis |
|
| Emerging Diagnostic Application Opportunities |
|
| Hospital Investment Prioritization Analysis |
|
Need a different cut of the data?
Request Custom ResearchHow large is the nuclear imaging equipment market?
How will the nuclear imaging equipment industry grow in terms of size and CAGR by 2036?
How are technology advancements shaping procurement strategies in the nuclear imaging equipment market?
Why is healthcare infrastructure expansion accelerating demand for nuclear imaging equipment?
Why is SPECT the leading modality in the nuclear imaging equipment market?
Which application is expanding fastest in the nuclear imaging equipment market?
Why is North America the largest nuclear imaging equipment market?
How is Asia Pacific expanding in the nuclear imaging equipment market?
Who holds a significant market share in the nuclear imaging equipment landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization